AGL: Agilon Health Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Agilon Health Inc (AGL).

OverviewDividends

$782.83M Market Cap.

As of 05/06/2025 5:00 PM ET (MRY) • Disclaimer

AGL Market Cap. (MRY)


AGL Shares Outstanding (MRY)


AGL Assets (MRY)


Total Assets

$1.73B

Total Liabilities

$1.26B

Total Investments

$211.74M

AGL Income (MRY)


Revenue

$6.06B

Net Income

-$260.15M

Operating Expense

$296.97M

AGL Cash Flow (MRY)


CF Operations

-$57.78M

CF Investing

$139.89M

CF Financing

-$2.58M

AGL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,733,983,000 (-0.40%)

$1,740,866,000 (2.56%)

$1,697,468,000 (7.01%)

$1,586,252,000 (255.37%)

Assets Current

$1,457,774,000 (-1.51%)

$1,480,076,000 (1.98%)

$1,451,274,000 (6.15%)

$1,367,195,000 (364.72%)

Assets Non-Current

$276,209,000 (5.91%)

$260,790,000 (5.93%)

$246,194,000 (12.39%)

$219,057,000 (43.96%)

Goodwill & Intangible Assets

$96,904,000 (10.24%)

$87,902,000 (319.36%)

$20,961,000 (-78.38%)

$96,938,000 (-4.97%)

Shareholders Equity

$470,952,000 (-28.84%)

$661,839,000 (-36.44%)

$1,041,220,000 (-4.64%)

$1,091,896,000 (483.48%)

Property Plant & Equipment Net

$28,169,000 (2.15%)

$27,576,000 (38.32%)

$19,937,000 (117.63%)

$9,161,000 (41.90%)

Cash & Equivalents

$193,860,000 (69.56%)

$114,329,000 (-75.98%)

$475,912,000 (-54.88%)

$1,054,820,000 (680.32%)

Accumulated Other Comprehensive Income

-$88,000 (96.17%)

-$2,298,000 (58.67%)

-$5,560,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$211,737,000 (-44.39%)

$380,773,000 (-7.56%)

$411,901,000 (0%)

$0 (0%)

Investments Current

$211,737,000 (-44.39%)

$380,773,000 (-7.56%)

$411,901,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,017,040,000 (7.91%)

$942,461,000 (91.42%)

$492,364,000 (67.81%)

$293,407,000 (102.97%)

Trade & Non-Trade Payables

$1,152,006,000 (17.89%)

$977,156,000 (104.33%)

$478,226,000 (35.88%)

$351,960,000 (35.31%)

Accumulated Retained Earnings (Deficit)

-$1,586,977,000 (-19.61%)

-$1,326,826,000 (-24.67%)

-$1,064,230,000 (-11.13%)

-$957,677,000 (-73.75%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$34,904,000 (8.04%)

$32,308,000 (-25.70%)

$43,482,000 (-10.16%)

$48,401,000 (-28.51%)

Debt Current

$0 (0%)

$0 (0%)

$5,000,000 (0.00%)

$5,000,000 (64.42%)

Debt Non-Current

$34,904,000 (8.04%)

$32,308,000 (-16.04%)

$38,482,000 (-11.33%)

$43,401,000 (-32.88%)

Total Liabilities

$1,263,031,000 (16.96%)

$1,079,845,000 (64.40%)

$656,859,000 (32.79%)

$494,656,000 (17.33%)

Liabilities Current

$1,152,006,000 (17.89%)

$977,156,000 (82.61%)

$535,091,000 (49.90%)

$356,960,000 (33.78%)

Liabilities Non-Current

$111,025,000 (8.12%)

$102,689,000 (-15.67%)

$121,768,000 (-11.57%)

$137,696,000 (-11.02%)

AGL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$6,060,530,000 (40.41%)

$4,316,363,000 (80.74%)

$2,388,220,000 (56.97%)

$1,521,494,000 (24.88%)

Cost of Revenue

$6,055,689,000 (42.60%)

$4,246,693,000 (86.52%)

$2,276,860,000 (56.40%)

$1,455,750,000 (29.49%)

Selling General & Administrative Expense

$268,912,000 (-5.90%)

$285,760,000 (37.52%)

$207,789,000 (-51.39%)

$427,502,000 (211.38%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$296,971,000 (-1.60%)

$301,803,000 (39.25%)

$216,738,000 (-50.51%)

$437,986,000 (190.40%)

Interest Expense

$6,177,000 (-7.22%)

$6,658,000 (48.48%)

$4,484,000 (-27.04%)

$6,146,000 (-24.45%)

Income Tax Expense

$1,451,000 (83.44%)

$791,000 (-51.77%)

$1,640,000 (85.10%)

$886,000 (2.43%)

Net Loss Income from Discontinued Operations

$9,824,000 (-85.46%)

$67,550,000 (364.13%)

$14,554,000 (-36.51%)

$22,925,000 (826.39%)

Consolidated Income

-$260,101,000 (1.03%)

-$262,803,000 (-145.92%)

-$106,864,000 (73.73%)

-$406,787,000 (-577.39%)

Net Income to Non-Controlling Interests

$50,000 (124.15%)

-$207,000 (33.44%)

-$311,000 (-3.67%)

-$300,000 (0%)

Net Income

-$260,151,000 (0.93%)

-$262,596,000 (-146.45%)

-$106,553,000 (73.79%)

-$406,487,000 (-576.89%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$260,151,000 (0.93%)

-$262,596,000 (-146.45%)

-$106,553,000 (73.79%)

-$406,487,000 (-576.89%)

Weighted Average Shares

$410,966,000 (0.50%)

$408,917,000 (0.19%)

$408,154,000 (9.44%)

$372,931,000 (15.29%)

Weighted Average Shares Diluted

$410,966,000 (0.50%)

$408,917,000 (0.19%)

$408,154,000 (9.44%)

$372,931,000 (15.29%)

Earning Before Interest & Taxes (EBIT)

-$252,523,000 (1.03%)

-$255,147,000 (-154.06%)

-$100,429,000 (74.86%)

-$399,455,000 (-682.45%)

Gross Profit

$4,841,000 (-93.05%)

$69,670,000 (-37.44%)

$111,360,000 (69.38%)

$65,744,000 (-30.17%)

Operating Income

-$292,130,000 (-25.85%)

-$232,133,000 (-120.29%)

-$105,378,000 (71.69%)

-$372,242,000 (-556.82%)

AGL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$139,891,000 (417.80%)

-$44,019,000 (90.09%)

-$444,388,000 (-391.00%)

-$90,506,000 (-510.16%)

Net Cash Flow from Financing

-$2,583,000 (98.66%)

-$193,133,000 (-788.38%)

$28,056,000 (-97.57%)

$1,154,390,000 (4588.64%)

Net Cash Flow from Operations

-$57,777,000 (63.01%)

-$156,199,000 (-19.41%)

-$130,808,000 (11.71%)

-$148,159,000 (-178.47%)

Net Cash Flow / Change in Cash & Cash Equivalents

$79,531,000 (120.22%)

-$393,351,000 (28.11%)

-$547,140,000 (-159.75%)

$915,725,000 (14151.33%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$43,059,000 (-8711.80%)

$500,000 (137.20%)

-$1,344,000 (-105.13%)

Net Cash Flow - Investment Acquisitions and Disposals

$181,176,000 (506.85%)

$29,855,000 (107.24%)

-$412,227,000 (-444.29%)

-$75,736,000 (-4133.43%)

Capital Expenditure

-$13,251,000 (16.29%)

-$15,830,000 (-2.62%)

-$15,426,000 (-135.01%)

-$6,564,000 (-269.80%)

Issuance (Repayment) of Debt Securities

-$3,750,000 (25.00%)

-$5,000,000 (0.00%)

-$5,000,000 (74.87%)

-$19,899,000 (-554.36%)

Issuance (Purchase) of Equity Shares

$1,167,000 (100.62%)

-$188,133,000 (-669.13%)

$33,056,000 (-97.22%)

$1,189,028,000 (4198.42%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$50,657,000 (-27.11%)

$69,495,000 (144.86%)

$28,381,000 (-90.29%)

$292,394,000 (4271.92%)

Depreciation Amortization & Accretion

$24,463,000 (21.34%)

$20,161,000 (46.39%)

$13,772,000 (-6.12%)

$14,670,000 (4.05%)

AGL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

0.10% (-93.75%)

1.60% (-65.96%)

4.70% (9.30%)

4.30% (-44.16%)

Profit Margin

-4.30% (29.51%)

-6.10% (-35.56%)

-4.50% (83.15%)

-26.70% (-444.90%)

EBITDA Margin

-3.80% (29.63%)

-5.40% (-50.00%)

-3.60% (85.77%)

-25.30% (-743.33%)

Return on Average Equity (ROAE)

-43.10% (-43.67%)

-30.00% (-206.12%)

-9.80% (81.47%)

-52.90% (-328.02%)

Return on Average Assets (ROAA)

-12.50% (-1.63%)

-12.30% (-108.47%)

-5.90% (79.86%)

-29.30% (-107.80%)

Return on Sales (ROS)

-4.20% (28.81%)

-5.90% (-40.48%)

-4.20% (84.03%)

-26.30% (-526.19%)

Return on Invested Capital (ROIC)

-50.50% (-30.15%)

-38.80% (-88.35%)

-20.60% (94.40%)

-368.10% (-13.82%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-3.02 (84.62%)

-19.61 (68.41%)

-62.08 (-150.60%)

-24.77

Price to Sales Ratio (P/S)

0.13 (-89.15%)

1.19 (-56.89%)

2.76 (-58.33%)

6.62

Price to Book Ratio (P/B)

1.66 (-78.41%)

7.7 (20.60%)

6.38 (-34.42%)

9.73

Debt to Equity Ratio (D/E)

2.68 (64.34%)

1.63 (158.64%)

0.63 (39.29%)

0.45 (130.59%)

Earnings Per Share (EPS)

-0.63 (1.56%)

-0.64 (-146.15%)

-0.26 (76.15%)

-1.09 (-473.68%)

Sales Per Share (SPS)

14.75 (39.70%)

10.56 (80.41%)

5.85 (43.41%)

4.08 (8.31%)

Free Cash Flow Per Share (FCFPS)

-0.17 (58.91%)

-0.42 (-17.60%)

-0.36 (13.73%)

-0.41 (-144.12%)

Book Value Per Share (BVPS)

1.15 (-29.22%)

1.62 (-36.53%)

2.55 (-12.88%)

2.93 (432.73%)

Tangible Assets Book Value Per Share (TABVPS)

3.98 (-1.46%)

4.04 (-1.61%)

4.11 (2.85%)

3.99 (275.02%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (84.21%)

-19 (68.85%)

-61 (-154.17%)

-24

Enterprise Value Over EBITDA (EV/EBITDA)

-2.91 (86.20%)

-21.09 (70.17%)

-70.71 (-183.95%)

-24.9

Asset Turnover

2.92 (44.43%)

2.02 (53.69%)

1.31 (19.87%)

1.1 (-61.78%)

Current Ratio

1.26 (-16.50%)

1.51 (-44.14%)

2.71 (-29.19%)

3.83 (247.23%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$71,028,000 (58.71%)

-$172,029,000 (-17.64%)

-$146,234,000 (5.49%)

-$154,723,000 (-181.42%)

Enterprise Value (EV)

$663,927,906 (-86.61%)

$4,957,050,596 (-19.10%)

$6,127,570,246 (-36.05%)

$9,582,421,421

Earnings Before Tax (EBT)

-$258,700,000 (1.19%)

-$261,805,000 (-149.54%)

-$104,913,000 (74.13%)

-$405,601,000 (-585.29%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$228,060,000 (2.95%)

-$234,986,000 (-171.17%)

-$86,657,000 (77.48%)

-$384,785,000 (-941.28%)

Invested Capital

$326,117,000 (-45.08%)

$593,787,000 (-16.25%)

$708,986,000 (462.98%)

$125,935,000 (1153.58%)

Working Capital

$305,768,000 (-39.20%)

$502,920,000 (-45.11%)

$916,183,000 (-9.31%)

$1,010,235,000 (3592.11%)

Tangible Asset Value

$1,637,079,000 (-0.96%)

$1,652,964,000 (-1.40%)

$1,676,507,000 (12.57%)

$1,489,314,000 (332.50%)

Market Capitalization

$782,833,906 (-84.64%)

$5,095,813,596 (-23.34%)

$6,647,336,246 (-37.46%)

$10,628,696,421

Average Equity

$602,933,250 (-31.03%)

$874,221,500 (-19.48%)

$1,085,679,250 (41.37%)

$767,973,750 (397.23%)

Average Assets

$2,076,293,000 (-2.77%)

$2,135,532,750 (17.60%)

$1,815,909,000 (30.94%)

$1,386,786,000 (226.63%)

Invested Capital Average

$500,283,000 (-23.95%)

$657,867,250 (34.71%)

$488,352,750 (349.98%)

$108,528,500 (587.41%)

Shares

412,017,845 (1.47%)

406,040,924 (-1.41%)

411,854,786 (4.62%)

393,655,423 (2.29%)